Eisai, Biogen move forward with Alzheimer ' s med after initial failure

The two drugmakers ' treatment was found to slow Alzheimer ’s progression at its highest dose, allowing the partnership to move forward with late-stage clinical trials
Source: PharmaManufacturing.com - Category: Pharmaceuticals Source Type: news